Cargando…
Extended anticoagulation after venous thromboembolism: should it be done?
Most physicians understand venous thromboembolism (VTE) to be an acute and time-limited disease. However, pathophysiological and epidemiological data suggest that in most patients VTE recurrence risk is not resolved after the first 6 months of anticoagulation. Recurrence rates are high and potential...
Autores principales: | Fernandes, Caio J., Calderaro, Daniela, Piloto, Bruna, Hoette, Susana, Jardim, Carlos Vianna Poyares, Souza, Rogério |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767720/ https://www.ncbi.nlm.nih.gov/pubmed/31558116 http://dx.doi.org/10.1177/1753466619878556 |
Ejemplares similares
-
Lung Cavities in Chronic Thromboembolic Pulmonary Hypertension
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2020) -
Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension
por: Gavilanes-Oleas, Francisca Alexandra, et al.
Publicado: (2018) -
New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016) -
Reperfusion in acute pulmonary thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2018) -
Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)